Merck expands CRISPR patent portfolio
12-05-2020
USITC investigates grey market IVF products
14-04-2020
Merck KGaA secures CRISPR patents in Japan and Singapore
27-11-2019
Vchal / Shutterstock.com
Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Merck KGaA, CRISPR, MilliporeSigma, patent, gene-editing, genetics, Udit Batra, genome
